A review on comparative studies addressing exosome isolation methods from body fluids
TS Martins, M Vaz, AG Henriques - Analytical and Bioanalytical Chemistry, 2023 - Springer
Exosomes emerged as valuable sources of disease biomarkers and new therapeutic tools.
However, extracellular vesicles isolation with exosome-like characteristics from certain …
However, extracellular vesicles isolation with exosome-like characteristics from certain …
Biomarkers used in Alzheimer's disease diagnosis, treatment, and prevention
YAR Mahaman, KS Embaye, F Huang, L Li, F Zhu… - Ageing research …, 2022 - Elsevier
Abstract Alzheimer's disease (AD), being the number one in terms of dementia burden, is an
insidious age-related neurodegenerative disease and is presently considered a global …
insidious age-related neurodegenerative disease and is presently considered a global …
L1CAM is not associated with extracellular vesicles in human cerebrospinal fluid or plasma
M Norman, D Ter-Ovanesyan, W Trieu, R Lazarovits… - Nature …, 2021 - nature.com
L1CAM is a transmembrane protein expressed on neurons that was presumed to be found
on neuron-derived extracellular vesicles (NDEVs) in human biofluids. We developed a …
on neuron-derived extracellular vesicles (NDEVs) in human biofluids. We developed a …
Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges
Extracellular vesicles (EVs), including exosomes, microvesicles, and oncosomes, are nano-
sized particles enclosed by a lipid bilayer. EVs are released by virtually all eukaryotic cells …
sized particles enclosed by a lipid bilayer. EVs are released by virtually all eukaryotic cells …
L1CAM‐associated extracellular vesicles: A systematic review of nomenclature, sources, separation, and characterization
DE Gomes, KW Witwer - Journal of Extracellular Biology, 2022 - Wiley Online Library
When released into biological fluids like blood or saliva, brain extracellular vesicles (EVs)
might provide a window into otherwise inaccessible tissue, contributing useful biomarkers of …
might provide a window into otherwise inaccessible tissue, contributing useful biomarkers of …
Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer
AR Farina, L Cappabianca, M Sebastiano… - Journal of Experimental …, 2020 - Springer
Hypoxia-induced alternative splicing is a potent driving force in tumour pathogenesis and
progression. In this review, we update currents concepts of hypoxia-induced alternative …
progression. In this review, we update currents concepts of hypoxia-induced alternative …
Alternative splicing and related RNA binding proteins in human health and disease
Y Tao, Q Zhang, H Wang, X Yang, H Mu - Signal Transduction and …, 2024 - nature.com
Alternative splicing (AS) serves as a pivotal mechanism in transcriptional regulation,
engendering transcript diversity, and modifications in protein structure and functionality …
engendering transcript diversity, and modifications in protein structure and functionality …
Plasma-borne indicators of inflammasome activity in Parkinson's disease patients
FL Anderson, KM von Herrmann, AS Andrew… - NPJ Parkinson's …, 2021 - nature.com
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor and non-
motor symptoms and loss of dopaminergic neurons of the substantia nigra. Inflammation and …
motor symptoms and loss of dopaminergic neurons of the substantia nigra. Inflammation and …
[HTML][HTML] Circular RNAs: novel actors of Wnt signaling pathway in lung cancer progression
M Alimohammadi, Y Gholinezhad, V Mousavi… - EXCLI …, 2023 - ncbi.nlm.nih.gov
Abstract Circular RNAs (CircRNAs) are a class of regulatory RNA transcripts, which are
ubiquitously expressed in eukaryotes. CircRNA dysregulation has been shown to disrupt the …
ubiquitously expressed in eukaryotes. CircRNA dysregulation has been shown to disrupt the …
Direct full-length RNA sequencing reveals unexpected transcriptome complexity during Caenorhabditis elegans development
Massively parallel sequencing of the polyadenylated RNAs has played a key role in
delineating transcriptome complexity, including alternative use of an exon, promoter, 5′ or …
delineating transcriptome complexity, including alternative use of an exon, promoter, 5′ or …